| Name | No. | For Patients with | Purpose |
|---|---|---|---|
| SHAMROCK study | 22-01 | Patient with newly diagnosed early stage HER2-positive breast cancer with tumour size larger than 2cm |
The goal of this study is to investigate how effective neoadjuvant treatment with trastuzumab deruxtecan is for patients with early stage locally advanced HER2 positive breast cancer. |
DSSG Group: Breast
Proteomics / Molecular Breast
| Name | No. | For Patients with | Purpose |
|---|---|---|---|
| Proteomics / Molecular Breast | 09-07 | Breast cancer |
The purpose of this trial is to examine the function of different genes and proteins, previously identified to be of interest, and identify new ones, as well as the means by which they interact and differ between cancer cells. |